CMS plans to put in place new hospital procedure codes starting Aug. 1 that will allow the agency and other insurers to track the use and effectiveness of COVID-19 treatments in real-time. “CMS is implementing new procedure codes to allow Medicare and other insurers to identify the use of the therapeutics remdesivir and convalescent plasma for treating hospital in-patients with COVID-19,” CMS notified Capitol Hill on Thursday (July 30). “These new codes, which go into effect August 1, will enable...